External beam radiation therapy (EBRT) remains the mainstay for treating bone metastases, according to a new American Society for Radiation Oncology guideline for the use of radiation therapy in treating bone metastases.
External beam radiation therapy (EBRT) remains the mainstay for treating bone metastases, according to a new American Society for Radiation Oncology guideline for the use of radiation therapy in treating bone metastases.
?
The guideline, developed by ASTRO’s Oncology Clinical Affairs and Quality Committee, was published online in the International Journal of Radiation Oncology Biology Physics (Jan. 27, 2011).
"Radiation therapy is commonly used to treat bone metastases and has been proven very effective, but with the variety of radiation therapies available and range of successful fractionation schedules, it’s important to provide physicians with this guideline to assure they are using the most appropriate methods in treating patients," said lead author Stephen Lutz, MD, of Blanchard Valley Regional Cancer Center, Findlay, OH.
Some of the committee’s findings include:
From evidence to practice: Dr. Makarov discusses implementation science in urology
July 25th 2024“What our major contribution is, I think as urologists doing implementation science, is determining the important questions, which we are particularly well-suited to do because we're taking care of the patients,” says Danil V. Makarov, MD, MHS.